Quebec City, August 11, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, announced today that Mr. R.M. (Ric) Rumble, CEO of TSO3, will be giving a corporate presentation at 11:00 a.m (ET) today, at the Canaccord Genuity Annual Growth Conference.
TSO3 will offer a live audio webcast of its presentation, as well as an archived replay, which may be accessed at the following address: http://wsw.com/webcast/canaccord4/tos/
2011 Canaccord Genuity Growth Conference
August 9-11, 2011
Intercontinental Boston Hotel, Boston, Massachusetts
More information: http://www.canaccordgenuity.com
TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals.
TSO3’s new generation sterilizer intended for use in Central Sterilization Departments in hospitals, is under a multi-year global license agreement with 3M™ Infection Prevention Division.
The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other
risks and uncertainties.
The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
-30-Back to Posts